• 1.

    Hefny HM, Abualfadl EM, Youssef EA, Ismail MA, Soliman TM, Ahmed AR et al (2021) Urinary epidermal growth factor as a marker for lupus nephritis: clinical, laboratory, and histopathological study. Egypt Rheumatol Rehabil 48(13). https://doi.org/10.1186/s43166-021-00063-4

  • 2.

    Abdel-Monem SM, Ganeb SS, Fawzy RM, Bendary AM, Elhawary ZN (2019) Carotid artery atherosclerosis and ECG changes in patients with systemic lupus erythematosus: relation to disease activity and severity. Egypt Rheumatol Rehabil 46:71–77

    Article 

    Google Scholar
     

  • 3.

    Liu G, Wang H, Le J, Lan L, Xu Y, Yang Y et al (2019) Early-stage predictors for treatment responses in patients with active lupus nephritis. Lupus 28(3):283–289

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • 4.

    Brugos B, Kiss E, Szodoray P, Szegedi G, Zeher M (2006) Retrospective analysis of patients with lupus nephritis: Data from a large clinical immunological centrein Hungary. Scand J Immunol 64(4):433–437

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • 5.

    Zappitelli M, Duffy CM, Bernard C, Gupta IR (2008) Evaluation of activity, chronicity and tubulointerstitial indices for childhood lupus nephritis. Pediatr Nephrol 23(1):83–91

    Article 
    PubMed 

    Google Scholar
     

  • 6.

    Mosca M, Van Vollenhoven R (2013) New drugs in systemic lupus erythematosus: when to start and when to stop. Clin Exp Rheumatol 31(4 Suppl. 78):S82–S85

    PubMed 

    Google Scholar
     

  • 7.

    Brunner HI, Bennett MR, Mina R, Suzuki M, Petri M, Kiani AN et al (2012) Association of non-invasively measured renal protein biomarkers with histologic features of lupus nephritis. Arthritis Rheum 64(8):2687–2697

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 8.

    Feldt J, Schicht M, Garreis F, Welss J, Schneider UW, Paulsen F (2019) Structure, regulation and related diseases of the actin binding protein gelsolin. Expert Rev Mol Med 20:e7. https://doi.org/10.1017/erm.2018.7 PMID: 30698126

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • 9.

    Bucki R, Levental I, Kulakowska A, Janmey PA (2008) Plasma gelsolin: function, prognostic value, and potential therapeutic use. Curr Protein Pept Sci 9(6):541–551

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • 10.

    Silacci P, Mazzolai L, Gauci C, Stergiopulos N, Yin HL, Hayoz D (2004) Gelsolin superfamily proteins: key regulators of cellular functions. Cell Mol Life Sci 61(19–20):2614–2623

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • 11.

    Huang LF, Yao YM, Li JF, Dong N, Liu C, Yu Y et al (2011) Reduction of plasma gelsolin levels correlates with development of multiple organ dysfunction syndrome and fatal outcome in burn patients. PLoS One 6(11):e25748

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 12.

    DiNubile MJ (2008) Plasma gelsolin as a biomarker of inflammation. Arthritis Res Ther 10(6):124

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 13.

    Li Chun HK, Schob S, Zeller M, Pulli B, Ali M, Wang C et al (2015) Gelsolin decreases actin toxicity and inflammation in murine multiple sclerosis. J Neuroimmunol 287:36–42

    Article 

    Google Scholar
     

  • 14.

    Baig RM, Mahjabeen I, Sabir M, Masood N, Ali K, Malik FA et al (2013) Mutational spectrum of Gelsolin and its down regulation is associated with breast cancer. Dis Markers 34(2):71–80

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 15.

    Cheng Y, Hu X, Liu C, Chen M, Wang J, Gao F et al (2017) Gelsolin inhibits the inflammatory process induced by LPS. Cell Physiol Biochem 41(1):205–212

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • 16.

    Peddada N, Sagar A, Ashish GR (2012) Plasma gelsolin: a general prognostic marker of health. Med Hypotheses 78(2):203–210

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • 17.

    Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Goldman RR (2019) 2019 European League against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis 78(9):1151–1159

    Article 
    PubMed 

    Google Scholar
     

  • 18.

    Gladman DD, Ibanez D, Urowitz MB (2002) Systemic lupus erythematosus disease activity index 2000. J Rheumatol 29(2):288–291

    PubMed 

    Google Scholar
     

  • 19.

    Ghazali WSW, Daud SMM, Mohammad N, Wong KK (2018) SLICC damage index score in systemic lupus erythematosus patients and its associated factors. Medicine 97(42):e12787

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 20.

    Markowitz GS, D’agati VD (2007) The ISN/RPS 2003 classification of lupus nephritis: an assessment at 3 years. Kidney Int 71(6):491–495

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • 21.

    Mohamed DF, AB AA, Hassan SA, Shedid NH, El-Owaidy RH, Teama MA (2018) Juvenile lupus: Different clinical and serological presentations compared to adult lupus in Egypt. Egypt Rheumatol 40(1):55–58

    Article 

    Google Scholar
     

  • 22.

    Gheita TA, Noor RA, Abualfadl E, Abousehly OS, El-Gazzar II, Egyptian College of Rheumatology (ECR) SLE Study Group (2021) Adult systemic lupus erythematosus in Egypt: The nation-wide spectrum of 3661 patients and world-wide standpoint. Lupus 30(9):1526–1535

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • 23.

    Abdelazeem ME, Abdelhaleem MI, Mohamed RA et al (2021) The role of Dickkopf-1 as a biomarker in systemic lupus erythematosus and active lupus nephritis. Egypt Rheumatol Rehabil 48:15. https://doi.org/10.1186/s43166-021-00064-3

    Article 

    Google Scholar
     

  • 24.

    Batool S, Ahmad NM, Saeed MA, Farman S (2016) Pattern of initial clinical manifestations of systemic lupus erythematosus in a tertiary care hospital. Pak J Med Sci 32(5):1066–1070

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 25.

    Hu Y, Chen T, Liu S, Liu B, Meng H, Zhang L et al (2016) Gelsolin deposits in renal tissues of the patients with lupus nephritis. Int J Clin Exp Pathol 9:5413–5420

    CAS 

    Google Scholar
     

  • 26.

    Hu Y, Li H, Li WH, Meng HX, Fan YZ, Li WJ et al (2013) The value of decreased plasma gelsolin levels in patients with systemic lupus erythematosus and rheumatoid arthritis in diagnosis and disease activity evaluation. Lupus 22(14):1455–1461

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • 27.

    Piktel E, Levental I, Durnaś B, Janmey PA, Bucki R (2018) Plasma Gelsolin: Indicator of Inflammation and Its Potential as a Diagnostic Tool and Therapeutic Target. Int J Mol Sci 19(9):2516

    Article 
    PubMed Central 

    Google Scholar
     

  • 28.

    Parra S, Heras M, Herrero P, Amigó N, Garcés E, Girona J et al (2020) Gelsolin: a new biomarker of disease activity in SLE patients associated with HDL-c. Rheumatology 59(3):650–661

    CAS 
    PubMed 

    Google Scholar
     

  • 29.

    Mittoo S, Gelber AC, Hitchon CA, Silverman ED, Pope JE, Fortin PR et al (2010) Clinical and serologic factors associated with lupus pleuritis. J Rheumatol 37(4):747–753

    Article 
    PubMed 

    Google Scholar
     

  • 30.

    Esawy MM, Makram WK, Albalat W, Shabana MA (2020) Plasma gelsolin levels in patients with psoriatic arthritis: a possible novel marker. Clin Rheumatol 39:1881–1888

    Article 
    PubMed 

    Google Scholar
     

  • 31.

    Huang H, Song WQ, Li Y (2021) The gelsolin level in patients with primary Sjogren’s syndrome. Eur Rev Med Pharmacol Sci 25(4):2072–2078

    CAS 
    PubMed 

    Google Scholar
     

  • 32.

    Osborn TM, Verdrengh M, Stossel TP, Tarkowski A, Bokarewa M (2008) Decreased levels of the gelsolin plasma isoform in patients with rheumatoid arthritis. Arthritis Res Ther 10(5):R117

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 33.

    Dimitrijević J, Dukanović L, Kovacević Z, Bogdanović R, Maksić D, Hrvacević R et al (2002) Lupus nephritis: histopathologic features, classification and histologic scoring in renal biopsy. Vojnosanit Pregl 59(6Suppl):21–31

    PubMed 

    Google Scholar
     

  • 34.

    Misra R, Gupta R (2015) Biomarkers in lupus nephritis. Int J Rheum Dis 18(2):219–232

    Article 
    PubMed 

    Google Scholar
     

  • Rights and permissions

    Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

    Disclaimer:

    This article is autogenerated using RSS feeds and has not been created or edited by OA JF.

    Click here for Source link (https://www.springeropen.com/)